Marker Therapeutics, Inc. (MRKR)

1.18 -0.06 (-4.84%) USD  |  NASDAQ  |  Sep 04, 16:00
1.18 0.00 (0.00%) After-Hours: 20:00
More

Marker Therapeutics SG&A Expense (TTM) : 4.244M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 4.244M
March 31, 2026 4.045M
December 31, 2025 4.185M
September 30, 2025 4.365M
June 30, 2025 4.196M
March 31, 2025 4.393M
December 31, 2024 4.242M
September 30, 2024 4.592M
June 30, 2024 5.150M
March 31, 2024 6.526M
December 31, 2023 7.476M
September 30, 2023 7.714M
June 30, 2023 9.536M
March 31, 2023 10.53M
December 31, 2022 12.10M
September 30, 2022 13.47M
June 30, 2022 13.48M
March 31, 2022 13.52M
December 31, 2021 12.92M
September 30, 2021 12.46M
June 30, 2021 11.79M
March 31, 2021 10.78M
December 31, 2020 10.47M
September 30, 2020 9.861M
June 30, 2020 9.825M
Date Value
March 31, 2020 9.998M
December 31, 2019 9.977M
September 30, 2019 25.24M
June 30, 2019 25.26M
March 31, 2019 25.59M
December 31, 2018 24.38M
September 30, 2018 8.447M
June 30, 2018 8.445M
March 31, 2018 6.582M
December 31, 2017 6.412M
September 30, 2017 6.302M
June 30, 2017 5.365M
March 31, 2017 5.352M
December 31, 2016 4.692M
September 30, 2016 5.681M
June 30, 2016 5.038M
March 31, 2016 4.797M
December 31, 2015 4.448M
September 30, 2015 4.880M
June 30, 2015 4.234M
March 31, 2015 3.406M
December 31, 2014 3.182M
September 30, 2014 1.394M
June 30, 2014 1.331M
March 31, 2014 1.551M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Krystal Biotech, Inc. 159.89M
Ironwood Pharmaceuticals, Inc. 64.55M
SELLAS Life Sciences Group, Inc. 14.87M
Rezolute, Inc. 27.48M
Larimar Therapeutics, Inc. 21.65M